Table 5.
Recipient Site Complications
| Single Surgeon | Co-surgeon | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | RTOR | Flap Loss | Fat Necrosis | SSI | Wound | Seroma | Hematoma | RTOR | Flap Loss | Fat Necrosis | SSI | Wound | Seroma | Hematoma |
| Haddock et al1 | 8.6% | 1.4% | 4.3% | 4.3% | 21.4% | 7.1% | 2.9% | 4.3% | 1.4% | 5.1% | 3.6% | 16.7% | 2.2% | 1.5% |
| Bauermeister et al25 | 4% | 4% | — | 4% | 15% | 0% | 0% | 4% | 0% | — | 0% | 26% | 0% | 4% |
| Gösseringer et al26 | 25% | 12.5% | — | — | — | — | — | 14% | 0% | — | — | — | — | — |
| Razdan et al27 | 16.2% | 3.75% | 5% | 5% | — | 1.25% | 1.25% | 3.57% | 0.9% | 0% | 0% | — | 0.9% | 0% |
| Weichman et al28 | — | 0% | 2.6% | — | 2.6% | — | 2.5% | — | 0.6% | 4.7% | — | 4.1% | — | 2.9% |
| Asaad et al29 | 5.83% | 0.44% | — | 1.57% | — | 1.65% | 1.22% | 7.31% | 0.52% | — | 2.44% | — | 0.96% | 1.57% |
| Mericli et al30 | 13.9% | 0% | — | 3.2% | 11.8% | 3.7% | 5.7% | 5% | 0% | — | 0% | 7.6% | 0% | 4% |
SSI, surgical site infection.